NCT03179904 2026-02-24TVB-2640 and Trastuzumab With Paclitaxel or Endocrine Therapy for Treatment of HER2 Positive Metastatic Breast CancerMayo ClinicPhase 2 Active not recruiting17 enrolled 10 charts
NCT03101748 2026-02-12Neratinib and Paclitaxel With or Without Pertuzumab and Trastuzumab Before Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Breast CancerM.D. Anderson Cancer CenterPhase 1/2 Terminated34 enrolled 15 charts